This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Liver transplantation in chronic hepatitis B infection

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

One year survival is less than 50% compared to figures above 90% in patients with cholestatic or alcoholic liver disease.

Active pre-transplant viral replication - HBeAg +ve or HBV DNA +ve - is associated with a poorer prognosis.

Post-transplant reinfection occurs in nearly all cases. The likelihood is greatest in patients who were HBV DNA +ve at the time of transplantation.

High dose immunoglobulin perioperatively and postoperatively is the most effective way of delaying and preventing HBV recurrence.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.